Tuya Pal
Associate Director, Clinical Cancer Genomics, Vanderbilt-Ingram Cancer Center · Vanderbilt University Medical Center
Credentials: · · · · · ·
History
- 1999–2001
Women's College Research Institute
- 1996–1997
- 1988–1992
Research
Journal of the National Comprehensive Cancer Network · 2021 · 914 citations
A Population-Based Study of Genes Previously Implicated in Breast Cancer
New England Journal of Medicine · 2021 · 692 citations
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
Cancer · 2005 · First of 14 authors · 568 citations
28 papers
24 papers
24 papers
24 papers
- CE
16 papers
15 papers
15 papers
14 papers
Grants
- 2011–2027
Administrative Supplement: (2/3) MMC, VICC, and TSU: Partners in Eliminating Cancer Disparities
National Cancer Institute · U54
Contact PI · $11.6M · Vanderbilt University Medical Center
- 2021–2027
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
National Cancer Institute · UH3
PI · $8.6M · Vanderbilt University Medical Center
- 2020–2026
IMProving Care After Inherited Cancer Testing (IMPACT) Study
National Cancer Institute · U01
Contact PI · $4M · Vanderbilt University Medical Center
- 2019–2026
Enhancing Cancer Care Of Rural Dwellers Through Telehealth and Engagement (ENCORE)
National Cancer Institute · R01
PI · $3.6M · Vanderbilt University Medical Center
Clinical trials
- 2022–2028
Improving Care After Inherited Cancer Testing
Principal investigator · Active not recruiting
Vanderbilt-Ingram Cancer Center
- 2017–2035